Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Two-State Receptor Model01:29

The Two-State Receptor Model

3.6K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.6K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

6.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

4.9K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.9K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.8K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.5K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

4.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meta-analysis reveals microbiome signatures for colorectal cancer that are universal across age groups and sequencing methods.

Cell host & microbe·2026
Same author

Functional and ecological drivers of bacterial interactions in glacier-fed stream biofilms.

mSystems·2026
Same author

JPT2/HN1L functions as an NAADP-binding protein in a cell-type-specific manner.

Cell calcium·2026
Same author

Covalent Chemical Tagging of Transmembrane Transport Proteins Illuminates the Internalization Pathways of Xenosiderophores.

Journal of the American Chemical Society·2026
Same author

Nucleotide-Derived Competitive Inhibitors of Ectonucleotidase CD39─A Promising Extracellular Target for Immunotherapy of Cancer.

Journal of medicinal chemistry·2026
Same author

Capturing transient states of heterodimeric ABC transporter TM287/288 by time-resolved small-angle X-ray scattering.

Biophysical journal·2026

Related Experiment Video

Updated: Apr 11, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
12:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.7K

Domain-Specific Agonist Binding Affinities Explain Structural and Functional Regulation of TRPM2.

Tatiana Kupriianova1,2, Tessa Schwarzer3, Thorben Thalacker1,2

  • 1European Molecular Biology Laboratory, Hamburg, Germany.

Biorxiv : the Preprint Server for Biology
|April 10, 2026
PubMed
Summary

The TRPM2 channel

More Related Videos

A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
08:35

A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice

Published on: March 17, 2015

15.9K
Purification and Reconstitution of TRPV1 for Spectroscopic Analysis
11:53

Purification and Reconstitution of TRPV1 for Spectroscopic Analysis

Published on: July 3, 2018

8.5K

Related Experiment Videos

Last Updated: Apr 11, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
12:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.7K
A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
08:35

A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice

Published on: March 17, 2015

15.9K
Purification and Reconstitution of TRPV1 for Spectroscopic Analysis
11:53

Purification and Reconstitution of TRPV1 for Spectroscopic Analysis

Published on: July 3, 2018

8.5K

Area of Science:

  • Molecular Biology
  • Biophysics
  • Cell Physiology

Background:

  • TRPM2 is a calcium-permeable channel activated by ADP-ribose (ADPR) and oxidative stress.
  • The roles of its two nucleotide-binding domains, MHR1/2 and NUDT9H, in TRPM2 activation are not fully understood.

Purpose of the Study:

  • To quantitatively determine the ligand-binding affinities of isolated human TRPM2 MHR1/2 and NUDT9H domains.
  • To elucidate the relative contributions of these domains to TRPM2 channel activation by ADPR and its analogs.

Main Methods:

  • Biophysical techniques (e.g., surface plasmon resonance) were used to measure binding affinities.
  • Mutational analysis was performed to assess the functional impact of domain alterations.
  • Intracellular ADPR concentrations were quantified in resting and stimulated cells.

Main Results:

  • The MHR1/2 domain exhibits high-affinity binding to ADPR (Kd ≈ 0.5 µM), while NUDT9H shows significantly lower affinity (Kd ≈ 192 µM).
  • Mutations in MHR1/2 strongly impact ligand binding and channel gating, whereas NUDT9H mutations have modest effects.
  • Intracellular ADPR levels are generally below the affinity threshold for significant NUDT9H binding.

Conclusions:

  • High-affinity ADPR binding to the MHR1/2 domain is sufficient for TRPM2 channel activation under physiological conditions.
  • The NUDT9H domain likely plays a structural role rather than directly mediating ligand-dependent activation.
  • These findings provide a quantitative basis for understanding TRPM2 regulation by ADPR.